chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a headache, extreme fatigue, nausea, aches, fever, and chills for 24 hours beginning at 8:00pm the day that I received the vaccine. I had a burning sensation and lypmhadenopathy in the armpit of my injection arm, significant pain at injection site, with slight tingling and numbness radiating down to the hand of my injection arm as well. I took 1,000mg of Tylenol every 6 hours for 24 hours, which provided minimal symptom relief. All symtpoms were relived within 72 hours of receiving the vaccine.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: After administration he was fine for about 30 seconds. While in the chair he tilted his head back and became rigid then slumped over. I tried to awake him but he did not respond and became pale. His pulse was weak. I yelled into the pharmacy to call 911 . When I looked back his hands flew up in the air and he looked around. Upon talking to him he had passed out after piercings but never a shot. The EMTs checked his vitals they were ok and his parents picked him up.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with (Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received 27-OCT-2104 from the registered nurse who stated that it will take some time to get the (Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received on 13-NOV-2014 from the registered nurse concerning a patient (age range reported as 11, units not reported) of unknown gender. On 12-NOV-2014, the patient was vaccinated with a dose of (Merck) VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Approximately 3 to 3.5 hours after vaccination, patient developed a very sore arm, extreme nausea/ felt sick to her stomach. She said that she was not able to perform her normal daily activities and stayed in bed until she recovered. This lasted approximately 3 days.
Numbness on the right side of the body as well as dizziness, facial swelling and throat symptoms.
3 days after 2nd vaccine I had a large red itchy patch around the vaccination site. 8 days after the 2nd vaccine I had intense swelling under my eyes (about the size of a golf ball) Photos available by request.
Lymphadenopathy: under arms, around left and right collar bones, neck.  Fever Muscle Aches Joint pain Extreme Fatigue (ongoing) Headache
No adverse effects; second dose was administered 2/13/2019 and third dose was administered 8/5/2019 after first dose was administered 7 /2018 (unspecified date); This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date in July 2018, the patient was vaccinated with first dose of rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (route of administration, lot# and expiration date were not reported) for prophylaxis. On 13-FEB-2019, the patient was vaccinated with second dose of rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (route of administration, lot# and expiration date were not reported) for prophylaxis. On 05-AUG-2019, the patient was vaccinated with third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (route of administration, lot# and expiration date were not reported) for prophylaxis. No adverse effects were reported.
Patient presented to triage at 16:15.  Patient crying-large 4 x 5 cm bruise left thigh.  Continue over the counter medication and T #3 immunization received in AM.
Fever 103.6; Chills; Nausea; Dizzy, couldn't drive because I was so dizzy; Exhausted; Headache; Aching all over; This is a spontaneous report from a contactable consumer (patient) reporting for herself.  A 54-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6199, Expiry date: unknown), via an unspecified route of administration, administered in left shoulder of left arm on 17May2021 at 10:30 AM as dose 1, single for COVID-19 immunization at public health clinic/administration facility. Medical history included Bells palsy and allergy to walnuts, mold and fungus. There were no concomitant medications. Patient was not pregnant at vaccination. Patient did not test for covid prior vaccination. Patient did not get covid tested post vaccination. Patient did not take other vaccine in four weeks. No other medications in two weeks. On 19May2021, she experienced fever 103.6, chills, nausea, dizzy, she couldn't drive because she was so dizzy, exhausted, headache, aching all over. Patient did not take any treatment. Patient underwent lab data and procedure which included Body temperature 103.6 on 19May2021. Outcome of all events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
Puritic Confluent erythematous eruption left arm. Worsened over the course of one week then resolved over 2 days. There were no systemic symptoms.
This case was reported by a nurse call center representative and described the occurrence of injection site pain in a 73-year-old female patient who received SHINGRIX (batch number 3Z4KL, expiry date unknown). On 17th January 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 17th January 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain and injection site erythema. In January 2018, the outcome of the injection site pain and injection site erythema were recovered/resolved. The reporter considered the injection site pain and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The patient was a retired nurse practitioner. The patient received SHINGRIX in the left arm. The patient experienced pain and redness in left arm at injection site for first five and her arm was so sore that she could not sleep on that arm. The diameter of red spot was estimated by patient as 1 to 2 inches. The reported lot number (324KL) for SHINGRIX did not exist and was updated to 3Z4KL, according to sales database. For further tolerance to 2nd dose, refer linked cases US2018GSK050379. The patient was concerned about why her reactions would be different. The patient had PI.
I had pain on my right side from my neck down to my rib cage.  I went to the doctor and told me that I should got to the ER, but I didn't want to go.  So, he gave me a medicine that seem to help.  I was sick to my stomach.  I never vomit but I felt really sick.  Then the pains on my right side came back.  So, I went to the ER.  I was there for 4 days.  They did an x-ray on my lungs.  They said I had blood clots in both lungs.  They also did blood work.
"Redness, hot to touch within first 24 hours. Redness over 48 hours".
I felt like my wrist was stuck like I needed to shake it to make the bones reconnect it and it did not feel straight and it began to ache off and on. This lasted for several days and it did began just a few weeks after the COVID-19 vaccine. After one month I called a doctor and I saw him a few weeks later, he suggested putting a brace on it and he told me I was the second person he had seen regarding this after a COVID-19 vaccination. My wrist also had become weak.
Vaccinated on 08/10/21, mild symptoms until yesterday (08/22/21), standing outside 'under carport' & COMPLETELY just -fainted (passed out), hit head on concrete HARD (fell straight back) w/eyes open BUT NOT responding, was awaken (speech slightly slurred & head spinning plus I believe I've fractured or bruised my lower back/butt bone when I hit concrete so hard. Seemed medical attention (@ fire department & was told ambulance was gone (because of the Delta variant & the OVER STRESSED hospitals- I should see my Primary Care Physician) but I would need a CT/MRI done.
CHILD'S DATE OF BIRTH WRITTEN Incorrectly AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY INDIVIDUAL IDENTIFYING AS MOTHER.  CHILD IDENTIFIED IN database WITH correct date of birth. CHILD TOO YOUNG FOR VACCINE ON 8/18/2021.
Information was received 19-JUL-2017 from a lawyer regarding a case in litigation concerning a female plaintiff who was inoculated with ZOSTAVAX on or about 13-FEB-2009, administered by a physician as recommended for routine health maintenance and for the prevention of shingles.  It was reported that the vaccine did not prevent shingles as intended but rather caused the plaintiff to contract a persistent strain of herpes zoster.  On or about 09-AUG-2014 the plaintiff was treated by a physician for a blistering vesicular outbreak which was diagnosed as herpes zoster, or shingles. On or about 27-JUL-2015 the plaintiff was treated by a physician for new and continued shingles outbreaks.  On or about 29-AUG-2015 was treated by a physician for worsening and persistent vesicular lesions.  The plaintiff had been prescribed acyclovir (ZOVIRAX) and pain medicine for management of her painful symptoms.  As a direct and proximate result of these malfunctions, the plaintiff suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the plaintiff had suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information was requested.
This spontaneous report was received from a licensed practical nurse via a company representative concerning a 4 year old female patient. On 29-AUG-2013, the patient was vaccinated with a dose (dose 1) of PROQUAD (lot number and expiry date were reported as J007859 and 28-DEC-2014 respectively, dose and route unspecified). No concomitant therapy was reported. Approximately on an unknown date in 2013, the patient was diagnosed with chickenpox after receiving PROQUAD (Merck). About 13 days after administration of PROQUAD (Merck), the mother of the patient brought the patient into the office of an unspecified physician. At the time of the visit, the mother of the patient stated that, about 2 weeks prior, spots that resembled bug bites began to appear on the skin of the patient. At the time of the visit, the patient had a varicella-like rash on her legs, her arms, her abdomen, the trunk of her body, the nape of her neck, and her face. At the time of the visit, some of these blisters had already crusted over and other new ones were still cropping up. It was unspecified if any treatment was provided or if any lab tests were performed. It was reported that this was the second dose of varicella vaccine component of the patient 9dose 1 of PROQUAD). She was previously vaccinated with a dose of VARIVAX (Merck) at the 12-15 month recommended range. The outcome of chickenpox was unknown. The relatedness for chickenpox was unknown for PROQUAD (Merck). Additional information has been requested.
was administered 0.5 mL, should have been 0.25 mL for booster dose
hives w/facial swelling;seen in ER & treated w/Epi,DPH & taper dose of pred;resolved in 24hrs w/no reoccurrence
Systemic: Dizziness / Lightheadness-Mild, Additional Details: Paitent indicated that she has a history feeling faint or anxiety from shoots or tatttos, after vaccination patietn felt slightly dizzy, had patinet lay down raised legs, patient quickly began feeling better, ask patient if she wanted an ambulance, paitent responded no, that she feels fine, this has happened before. Patinets family picked her up. Follow up call with patient, at the end of the day, patient indicated no issues.
Vaccine frozen rather than refrigerated. Dose administered. Offered revaccination. Will consider revax
2 hours after the shot i thought I had got bitten by a mosquito because I had an itchy raised bump on my jaw I looked in the mirror and my left side of my neck was flame red then it spread to the front of my neck then it spread to the right side. It started  moving down to my chest. The rash started getting raised hives that looked like they were turning into blisters.. It was horribly itchy but the worst part is it felt like I had been scorched. Luckily I had antihistamines here on hand that eventually thank God turned it around. The next day on Monday I was in almost a comatose sleep like anesthesia I didn't know what day it was. Then on Tuesday my right side of my face went numb and felt like it was drawing down. My speech was slurry I was drooling out of my right side and I was having glitches with my memory. Today I'm still having speech difficulties gait problems and I'm hearing roaring in my ears. This is so terrifying.
Got the shot at 9 am. At around 8 pm my chest muscles seize up and made it incredibly difficult to breathe for 15 minutes, it eased up slightly after.  I also spiked a 103 degree fever overnight
Developed patchy, multibilliform rash, primarily over trunk; about 10 days after MMR.
This case was reported by a physician and described a 22 day old male pt who tested positive for hepatitis B core IgG and hep B surface antigen after receiving hep B vaccine recombinant (Engerix B) for prophylaxis. The infant's mother tested positive for hep B core antibody, which was "thought to be a result of a resolved hepatitis B infection." The infant's medical history and concurrent conditions were not reported. There were no concurrent medications. On 7/7/03, the pt received the 1st dose of Engerix B. On 7/8/13, 12 hrs post-immunization, tests for hep B core IgG and hep B surface antigen were positive. Repeat tests for hep B core IgG and hep B surface antigen performed on 7/16/03 were positive. The most recent info was received on 10/14/03. Serologies for hep B core IgG and hep B surface antigen were again negative on 8/29/03. The physician considered the infant's positive test for hep B core IgG to be possibly related to maternal transfer of the immunoglobulin and the positive test for hep B surface antigen to be related to administration of Engerix B only 12 hrs prior to the blood draw.
PAIN AT INJECTION SITE: FIRST DOSE WAS ADMINISTERED BY PHARMACY TECHNICIAN, PLUNGER DOES NOT MOVE, VACCINE STILL FULL WHEN WITHDREW.  PHARMACIST GAVE ANOTHER DOSE WITH NO ISSUE.  HOWEVER, PATIENT CAME BACK 4/5 COMPLAINING PAIN AT FIRST INJECTION SITE WAS A LOT THAT SHE COULD NOT MOVE HER ARM FOR A FEW DAYS.  SHE WENT TO THE DOCTOR ON 4/5 AND DR SAID IT COULD BE THAT THE SHOT WAS GIVEN NOT IN THE RIGHT SPOT WHICH MIGHT HAVE CAUSED NERVE DAMAGE.  PHARMACIST TRIED TO CALL DR ON 4/9 BUT HE WAS  NOT IN .  SPOKE TO PATIENT 4/7 AND SHE SAID HER PAIN WAS STILL A LOT EVEN THOUGH INFLAMMATION AND ARM MOVEMENT SEEM OKAY.
Patient started feeling itchy at the injection site. Patient felt not okay, No SOB, lightheadedness, hives or numbness.  Rapid Response was called and was advised extra observation time. No other intervention.
The pt developed a 4cm X 2cm reddened and slightly firm area. Treatment with ice application.
REPORTED SWELLING OF TONGUE AND UNUSUAL SENSATION IN THROUGHT TO EMERGENCY ROOM STAFF AT MEDICAL CENTER ON 11/07/2009, APPARENTLY ADMITTED FOR OBSERVATION AND DISCHARGED ON 11/08/2009.  UNKNOWN TREATMENT.  PATIENT DID NOT REPORT ANY PROBLEMS IMMEDIATELY FOLLOWING INJECTION. 11/10/09 Medical records received for dates 11/7/09 to 11/8/09. Hospital DX: Anaphylaxis. Presented to ER with c/o tongue swelling x1 day ago after H1N1 vax. worse this day, throat feels swollen c/o difficulty swallowing. Assessment: mild distress, tongue swelling with left side worse. Admitted.
Presents for fatigue, weakness, myalgia, diarrhea, N/V, cough. Admit for COVID & hyponatremia (no indication for steroids or remdesivir at time of admit). O2 demand increased by day 2 & pt started on dexamethasone & O2 via simple mask (does not tolerate NC per nursing). DC to facility.
1/2 hour post-vaccination 0340-0410 headache, sore throat, sore ears, chills.  FU 0500 dizzy, headache, no sore throat/ears/chills.  Is recovering.
Hypersensitive skin covering my torso and scalp; from my belly, armpits, chest, etc. I can feel my clothes rubbing against me at the slightest movement. I also get occasional chills from my torso thanks to the sensitivity.
Pt c/o throat fullness, numbness around mouth, pressure headache, lightheadedness, head feels hot, facial flushing, toes itching.
4/30/10 Received TC from school nurse, stating child had extremely red, tender left arm and redness extended down arm and fever. Advised her to inform parent to take child to PMD. ASAP for evaluation - seen by Dr. 4/30 who states area is infected and prescribed antibiotics. Seen and tx by PMD. To see Dr again Monday 5/3/10.
The patient was given the bivalent booster today 1/6/2023. His second dose of Moderna was given on 11/30/2022. The bivalent booster was administered prior to the two-month timeframe elapsing after his second dose. The patient did not exhibit any signs or symptoms of an adverse reaction.
This case was reported by a consumer via call center representative and described the occurrence of malaise in a 64-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced malaise. On an unknown date, the outcome of the malaise was recovered/resolved. It was unknown if the reporter considered the malaise to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. For tolerance to 2nd dose refer linked case US2018152727 for the same patient.
He developed a fever, chills, nausea and weakness.  We gave him Advil and put him to bed.  The next morning the fever was at 102.6.  It went down to 99.8 after more Advil, but then spiked up to 103.6 at around 5:00Pm on 1/29/2011.  He continued to have nausea, chills, weakness and dizziness in addition to fever.  The fever was gone by 1/30/2011 and he was pale and weak, but recovering.
Patient was given Pfizer monovalent vaccine as a first booster on 9/1/22
Bump at injection site.  Painful & swollen.  Hurts to move arm in certain directions.  Arm locks up.
Rash with blistering spanning shoulder blade to shoulder blade. Very itchy. And has lasted from 3 days after shot to present. There is some relief recently, I think it's finally healing up. Itching has let up some. I have had shingles and recurring painful rash associated with shingles before. I experienced a similar reaction after my first dose.
when patient was receiving vaccines , he was moving a lot when getting the vaccines. He moved and needle came out  then ma re inserted the needle without cleansing site again. 4 hours later he had a warm red  reaction on arm, 2 days later he come to the clinic and it is cellulitis, Doctor is Rx antibiotics.
Pt. was given 1 (0.5ml) vaccination of the Moderna Covid-19 Vaccine and patient should have received 1 shot of the Pfizer Covid-19 vaccine because of the patients age. Pt. has not experienced any adverse symptoms or events at this time which the date today is 1 day later on 8/9/2021.
Pfizer vaccine diluted with sterile water instead of diluent provided with Pfizer vaccine, clinical team working on follow up if revaccination needs to take place. No adverse events reported
Post vaccine 2/9/21, I experienced drop in O2 Sat over a period of several weeks as I log my daily vitals (blood sugar, BP, Temp, Pulse rate and O2 Sat in percent).  I have O2 concentrator that I use as needed via nasal cannula.  I do have SOB with exertion due to Sarcoidosis of the Lung.  I notified my PCP on 2/19 of a morning sat of 89 which came up with O2 and breathing exercises, I also took a 20mg. Lasix and Mucinex chewable which usually helps with congestion.  With O2 and rest, my O2 Sat improved and extra O2 was stopped.  Then again my O2 steadily dropped over a period of a week, I coughed more (always have come cough), SOB. On March 7th, getting ready for bed, I became severely SOB, O2 Sat now 82, I called 911.  Was alert, oriented when Paramedics arrived, but needed 100% O2 and transported to Hospital, SOB was severe, gasping/drowning, loss of awareness, apparently resp. arrested, was intubated.  STAT CT with Contrast, and Echocardiogram, R/O PE, Lung collapse, etc.  (No PE/or collapse). MY supposition is that I had a slow moving allergic response to Moderna Vaccine (I am a former healthcare worker of 20 years) and currently work in healthcare medical devices in Ultrasound.  I closely watch vaccine development and read research articles on Sarcoidosis, vaccines and COVID. I participated and continue with a Sarcoidosis Study). I think I experienced cytokine storm with my ultrasensitive immune system. I use oral steroid (QVAR 40mics inhaled daily) which I doubled after taking the vaccine for a few weeks. I have had a MMR vaccine last June 2020 and Quadvalent Flu vaccine last August 2020.
Information has been received from a woman in a medical office concerning a male patient over 50 years old who on June 21 2004 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 648139/0009P). Subsequently that week on approximately June 21 2004, the patient called the medical office and reported redness around the injection site and fever, Unspecified medical attention was sought. A product quality complaint was not involved. the reported also mentioned two female patients who had a similar experiences post vaccination with pneumococcal 23v polysaccharide vaccine (WAES0406USA02561). Additional information has been requested.
Developed a 102 degree fever 12 hours after vaccine. also chills and a very very sore arm.
Rash in blotches around injection site, showed up 8 days later, slightly itchy, warm to the touch
Very rapid heart beat; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Very rapid heart beat) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEART RATE INCREASED (Very rapid heart beat). At the time of the report, HEART RATE INCREASED (Very rapid heart beat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided.